Home/Filings/4/0001567619-19-006351
4//SEC Filing

Alleavitch Doug 4

Accession 0001567619-19-006351

CIK 0001444380other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 11:13 AM ET

Size

7.6 KB

Accession

0001567619-19-006351

Insider Transaction Report

Form 4
Period: 2019-03-05
Alleavitch Doug
VP, Quality and Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-05$42.30/sh+1,031$43,61127,016 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-03-051,03115,469 total
    Exercise: $42.30Exp: 2028-11-26Common Stock (1,031 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    1,517
Footnotes (2)
  • [F1]Includes 14,792 restricted stock units.
  • [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from November 27, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

NEVRO CORP

CIK 0001444380

Entity typeother

Related Parties

1
  • filerCIK 0001639099

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 11:13 AM ET
Size
7.6 KB